Susquehanna International Group’s Foundation Medicine, Inc. FMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-141,300
| Closed | -$19.3M | – | 10871 |
|
|
2018
Q2 | $19.3M | Sell |
141,300
-97,600
| -41% | -$8.86M | 0.01% | 1332 |
|
|
2018
Q1 | $18.8M | Buy |
238,900
+190,100
| +390% | +$14M | 0.01% | 1261 |
|
|
2017
Q4 | $3.33M | Sell |
48,800
-144,300
| -75% | -$7.48M | ﹤0.01% | 3077 |
|
|
2017
Q3 | $7.76M | Sell |
193,100
-62,800
| -25% | -$2.42M | ﹤0.01% | 2012 |
|
|
2017
Q2 | $10.2M | Buy |
255,900
+114,100
| +80% | +$4.18M | ﹤0.01% | 1681 |
|
|
2017
Q1 | $4.57M | Buy |
141,800
+67,800
| +92% | +$1.69M | ﹤0.01% | 2466 |
|
|
2016
Q4 | $1.31M | Sell |
74,000
-41,800
| -36% | -$901K | ﹤0.01% | 4958 |
|
|
2016
Q3 | $2.7M | Buy |
115,800
+20,900
| +22% | +$474K | ﹤0.01% | 3065 |
|
|
2016
Q2 | $1.77M | Buy |
94,900
+67,700
| +249% | +$1.22M | ﹤0.01% | 3787 |
|
|
2016
Q1 | $494K | Sell |
27,200
-93,700
| -78% | -$1.51M | ﹤0.01% | 6423 |
|
|
2015
Q4 | $2.55M | Buy |
120,900
+110,900
| +1,109% | +$2.14M | ﹤0.01% | 3595 |
|
|
2015
Q3 | $185K | Sell |
10,000
-30,900
| -76% | -$772K | ﹤0.01% | 8771 |
|
|
2015
Q2 | $1.38M | Sell |
40,900
-8,000
| -16% | -$322K | ﹤0.01% | 5499 |
|
|
2015
Q1 | $2.35M | Buy |
+48,900
| New | +$2.22M | ﹤0.01% | 4005 |
|
|
2014
Q3 | – | Sell |
-10,800
| Closed | -$291K | – | 10264 |
|
|
2014
Q2 | $291K | Buy |
+10,800
| New | +$274K | ﹤0.01% | 8435 |
|
Susquehanna International Group's FMI Position: Q2 2018 in Review
Susquehanna International Group sold out of Foundation Medicine, Inc. (FMI) in Q2 2018, closing a stake of 141,809 shares — an estimated $12.9M sold.
Susquehanna International Group first reported a position in FMI in Q1 2014 and held it in 15 quarters. The position peaked at $24.6M in Q1 2015. 157 funds tracked by Wall St. Rank hold FMI as of Q2 2018.
- Susquehanna International Group reported no remaining Foundation Medicine, Inc. position as of Q2 2018 after selling out during the quarter.
- Susquehanna International Group sold 141,809 Foundation Medicine, Inc. shares in Q2 2018, an estimated $12.9M.
- Susquehanna International Group first reported a position in Foundation Medicine, Inc. in Q1 2014 and held it in 15 quarters.
- Susquehanna International Group's Foundation Medicine, Inc. position peaked at $24.6M in Q1 2015.
- 157 funds tracked by Wall St. Rank held Foundation Medicine, Inc. as of Q2 2018.
Based on Susquehanna International Group's 13F filing for Q2 2018, filed 14 Aug 2018.